晚期卵巢癌TP方案化疗联合热疗疗效观察及护理  

Clinical effective and nursing of paclitaxel-cisplatin program chemotherapy combined with hyperthermia for advanced ovarian cancer

作　　者：田玉青 马印慧[2] 董丽娟 陈凤娟 

机构地区：[1]滦县人民医院,河北滦县063700 [2]唐山市妇幼保健院,河北唐山063000

出　　处：《西部医学》2012年第6期1193-1194,共2页Medical Journal of West China

摘　　要：目的观察TP方案化疗联合热疗治疗晚期卵巢癌疗效,总结护理体会。方法 60例晚期卵巢癌患者分为实验组和对照组,每组30例,实验组采用TP方案化疗联合热疗;对照组仅采用化疗。两组患者均予以相应的心理护理以及化疗和热疗的相关护理,观察实验组与对照组的近期疗效和不良反应。结果实验组近期有效率70%(21/30例),对照组为45.83%(13/30例),实验组明显高于对照组,差异有统计学意义(P<0.05)。实验组和对照组的不良反应无统计学差异(P>0.05)。结论 TP方案化疗联合热疗治疗晚期卵巢癌的患者疗效明显,不会增加不良反应。Objective To study the clinical efficacy and nursing care of paclitaxel-cisplatin program combined with hyperthermia treatment on advanced ovarian cancer. Methods 60 patients with advanced ovarian cancer were randomly divided into experimental group and control group, 30 patients in each group. The paclitaxel-cisplatin chemotherapy combined hyperthermia was used on the experimental grouP and the paclitaxel-cisplatin chemotherapy was used on the control group. The clinical efficacy and the adverse reactions were observed on the experimental and control group. All patients were cared with appropriate psychological and related to chemotherapy and hyperthermia. Results The efficacy rate was 70% （21/30） on the experimental group,the efficacy？ rate was 45.83 % （13/30） on the control group. The efficacy rate of experimental group was significantly increased compared with control （P〈0. 05）. The adverse reactions of experimental group and control group were not statistically significant. Conclusions The clinical effective of paclitaxel-cisplatin chemotherapy combined hyperthermia treatment for advanced ovarian cancer was significantly increased with simply paclitaxel-cisplatin chemotherapy,and the rate of adverse reactions was not increased.

关 键 词：卵巢癌 化疗 热疗 护理 

分 类 号：R737.31[医药卫生—肿瘤]